US release

05 . 11 .2018
Press release
Galderma Announces FDA Approval of Restylane® Lyft For Midface Injection via Cannula
  • U.S. release
25 . 10 .2018
Press release
Galderma Announces ASPIRE Rewards Program Reaches One Million Members
  • U.S. release
22 . 10 .2018
Press release
Fort Worth’s Galderma, Maker of Cetaphil, Presents the 4th Annual Wonder Run 5K and 1K Kids Waddle to Benefit Children’s Skin Disease Foundation
  • U.S. release
11 . 10 .2018
Press release
Galderma Initiates Six New Studies, Increasing Company’s Commitment to Aesthetic Research and Innovation
  • U.S. release
25 . 09 .2018
Press release
World-Renowned Celebrity and Fashion Manicurist Deborah Lippmann Joins Forces with Galderma on “Face Your Hands” Campaign to Help Women Achieve Younger-Looking Hands with Restylane® Lyft
  • U.S. release
21 . 05 .2018
Press release
Nestlé Skin Health Announces the FDA Approval of Restylane® Lyft for Hands, the First and Only Hyaluronic Acid (HA) Dermal Filler for Use in the Back of Hands
  • U.S. release
07 . 05 .2018
Press release
Galderma Announces Results of ALAMO: A Real-World, Phase 4 Study Demonstrating Efficacy and Safety of Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% Plus Oral Doxycycline 200 mg in Treating Severe Inflammatory Acne
  • U.S. release
30 . 04 .2018
Press release
New Phase 4 OSCAR Trial Data Showed that Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% Decreased Acne Lesions Therefore Reducing the Risk of Scars in Moderate-to-Severe Acne Patients
  • U.S. release
05 . 03 .2018
Press release
Leading Acne Brand Launches First-Ever ​Retinoid Education Week
  • U.S. release
21 . 02 .2018
Press release
Differin® Expands Portfolio with the Addition of Two New Facial Skincare Products
  • U.S. release